Profile
Sector:
HealthcareIndustry:
Medical DevicesCountry:
United StatesIPO:
22 May 2020Website:
http://www.inarimedical.comNext earnings report:
02 August 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | Fri, 05 Jul 2024 23:12:02 GMTDividend
Analysts recommendations
Institutional Ownership
Included in screeners
NARI Latest News
NEW YORK, NY / ACCESSWIRE / July 7, 2024 / If you suffered a loss on your Inari Medical, Inc. (NASDAQ:NARI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/inari-medical-inc-lawsuit-submission-form?prid=89571&wire=1 or contact Joseph E. Levi, Esq.
NEW YORK, NY / ACCESSWIRE / July 7, 2024 / If you suffered a loss on your Inari Medical, Inc. (NASDAQ:NARI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/inari-medical-inc-lawsuit-submission-form?prid=89585&wire=1 or contact Joseph E. Levi, Esq.
NEW YORK, July 07, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Inari Medical, Inc. (NASDAQ: NARI) between February 24, 2022 and February 28, 2024, both dates inclusive (the “Class Period”), of the important July 12, 2024 lead plaintiff deadline.
NEW YORK, NY / ACCESSWIRE / July 7, 2024 / If you suffered a loss on your Inari Medical, Inc. (NASDAQ:NARI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/inari-medical-inc-lawsuit-submission-form?prid=89572&wire=1 or contact Joseph E. Levi, Esq.
Contact Hagens Berman by July 12, 2024 Deadline to Join Class Action Against Inari Medical (NARI) SAN FRANCISCO, CA / ACCESSWIRE / July 7, 2024 / Hagens Berman urges Inari Medical, Inc. (NASDAQ:NARI) investors who suffered substantial losses to submit your losses now. Class Period: Feb. 24, 2022 - Feb. 28, 2024 Lead Plaintiff Deadline: July 12, 2024 Visit: www.hbsslaw.com/investor-fraud/nari Contact the Firm Now: [email protected] 844-916-0895 Inari Medical Class Action: Inari Medical, Inc. (NASDAQ: NARI), a leading medical device manufacturer, finds itself embroiled in a complex legal battle as the U.S. Department of Justice (DOJ) intensifies its scrutiny.
LOS ANGELES, CA / ACCESSWIRE / July 7, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Inari Medical, Inc. ("Inari" or "the Company") (NASDAQ:NARI) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 24, 2022 and February 28, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before July 12, 2024.
NEW YORK, July 07, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Inari Medical, Inc. (“Inari” or the “Company”) (NASDAQ: NARI). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
NEW YORK, NY / ACCESSWIRE / July 7, 2024 / If you suffered a loss on your Inari Medical, Inc. (NASDAQ:NARI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/inari-medical-inc-lawsuit-submission-form?prid=89543&wire=1 or contact Joseph E. Levi, Esq.
NEW YORK, NY / ACCESSWIRE / July 6, 2024 / If you suffered a loss on your Inari Medical, Inc. (NASDAQ:NARI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/inari-medical-inc-lawsuit-submission-form?prid=89471&wire=1 or contact Joseph E. Levi, Esq.
NEW YORK, NY / ACCESSWIRE / July 6, 2024 / If you suffered a loss on your Inari Medical, Inc. (NASDAQ:NARI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/inari-medical-inc-lawsuit-submission-form?prid=89470&wire=1 or contact Joseph E. Levi, Esq.
What type of business is Inari Medical?
Inari Medical is a company that manufactures specialized medical equipment for minimally invasive treatment of patients suffering from venous diseases. It was founded in 2011 and is headquartered in Irvine, California. The company began its direct commercial activities in 2017 after the approval by the US Food and Drug Administration (FDA) of its first two devices: - ClotTriever for the treatment of deep vein thrombosis. - FlowTriever for the treatment of pulmonary embolism and clots in the right atrium.
What sector is Inari Medical in?
Inari Medical is in the Healthcare sector
What industry is Inari Medical in?
Inari Medical is in the Medical Devices industry
What country is Inari Medical from?
Inari Medical is headquartered in United States
When did Inari Medical go public?
Inari Medical initial public offering (IPO) was on 22 May 2020
What is Inari Medical website?
https://www.inarimedical.com
Is Inari Medical in the S&P 500?
No, Inari Medical is not included in the S&P 500 index
Is Inari Medical in the NASDAQ 100?
No, Inari Medical is not included in the NASDAQ 100 index
Is Inari Medical in the Dow Jones?
No, Inari Medical is not included in the Dow Jones index
When does Inari Medical report earnings?
The next expected earnings date for Inari Medical is 02 August 2024